About Us
Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
The company is led by a seasoned management team and is supported by a network of world-leading experts in the field of ADC development.
Adcytherix is backed by a syndicate of leading life science investors including Pontifax, Pureos Bioventures, RA Capital Management and Dawn Biopharma (a platform controlled by KKR).
Adcytherix is based in Marseille, France.
Management Team
Jack Elands
Founder, Chief Executive Officer
Dr. Jack Elands is founder and former CEO of Emergence Therapeutics, Talix Therapeutics, CEO of BliNK Biomedical and CEO and co-founder of Amakem, CEO of Vitec, co-founder of MImAbs
Carsten Dehning
Co-founder, Chief Financial Officer
Carsten Dehning is co-founder and former CFO of Emergence Therapeutics, CFO, CEO and senior advisor of various companies and investors in the healthcare sector
Xavier Preville
Co-founder, VP and head of research & preclinical development
Dr. Xavier Preville is co-founder and former CSO of Emergence Therapeutics, CSO at Talix Therapeutics, director of preclinical development at Transgene and BT Pharma (Genticel)
Thierry Menguy
VP and head of CMC operations
Dr. Thierry Menguy is the former head of CMC at LinKinVax, CTO and co-founder at ElsaLys Biotech. He has also held senior positions in CMC and R&D of large molecules at Transgene
Inka Pawlitzky
VP and head of clinical development
Dr. Inka Pawlitzky is former senior medical director and program lead oncology at Faron Pharmaceuticals, director oncology development at Allucent and consultant at SMS Oncology
Julia Gavrilyuk
VP and head of ADC technology development
Dr. Julia Gavrilyuk is co-founder and former CEO of Yarrow Therapeutics, senior principal scientist at Abbvie, head of discovery chemistry at Stemcentrx
Holger Karsunky
VP and head of ADC discovery
Dr. Holger Karsunky is co-founder and former CSO of Yarrow Therapeutics, senior director oncology discovery at Abbvie Stemcentrx and director preclinical at Cellerant Therapeutics
Supervisory Committee
Ran Nussbaum
Managing Partner at Pontifax Venture Capital
Ohad Hammer
Partner at Pontifax Venture Capital
Ximing Ding
Investment Manager at Pureos Bioventures
Iyona Rajkomar
Managing Partner at Dawn Biopharma (a platform controlled by KKR)
Matthew Hammond
Principal at RA Capital Management